loader from loading.io

Elizabeth Nielson and Ingmar Gorman - The Importance of Psychedelic Integration Training for Therapists

Psychedelics Today

Release Date: 02/18/2020

Dylan Beynon - Mindbloom: The Next Chapter in Mental Health and Wellbeing show art Dylan Beynon - Mindbloom: The Next Chapter in Mental Health and Wellbeing

Psychedelics Today

In this episode, Kyle sits down with Dylan Beynon, founder of Mindbloom, NYC based mental health and wellbeing platform. In the show they talk about how Mindbloom differs from other centers, paving the way for accessibility and affordability. 3 Key Points: Mindbloom is a next-generation mental health platform, catered to accessibility and affordability. They use ketamine tablets, different from lozenges and any other method. The tablets are held in the mouth and then spit out to avoid entering the liver, causing a sedation-like experience. Mindbloom differentiates themselves from other...

info_outline
Dr. Ryan Westrum - The Psychedelics Integration Handbook show art Dr. Ryan Westrum - The Psychedelics Integration Handbook

Psychedelics Today

In this episode, Kyle sits down with Dr. Ryan Westrum, Psychedelic Integration Therapist. In the show, they talk about topics and teachings from Ryan’s book, The Psychedelic Integration Handbook. 3 Key Points: The Psychedelics Integration Handbook is designed to bring psychedelic experiences into the flow of your life and maximize their potential for helping you create the life you want to live. There is an important part in distinguishing integration from aftercare. Aftercare can look as simple as taking care of your body, getting good rest, eating well. You can't integrate without taking...

info_outline
Jessica DiRuzza - Understanding the Psychedelic Experience with Astrology show art Jessica DiRuzza - Understanding the Psychedelic Experience with Astrology

Psychedelics Today

In this episode, Kyle interviews Jessica DiRuzza, Psychotherapist, Astrologer and Teacher. In the show they talk about how astrology can be used as a tool and framework for navigating and understanding psychedelic experiences. 3 Key Points: Astrology can be used as an integrative tool for psychedelic and other exceptional experiences. The planets are emitting some type of force that are letting us behave a certain way. Astrology is the one thing we have agreed upon across millennia and era. A Saturn Return transit can be a difficult but transformative time in one's life. This transit happens...

info_outline
Rob Heffernan - Psychedelic Liberty Summit: Religion and Plant Medicines show art Rob Heffernan - Psychedelic Liberty Summit: Religion and Plant Medicines

Psychedelics Today

In this episode, Kyle sits down with Rob Heffernan, an independent researcher and activist. In the show, they talk about churches, Ayahuasca, accessibility and the by the Chacruna Institute for Psychedelic Plant Medicines. Rob is also part of .  The Council for the Protection of Sacred plants is "an initiative of the Chacruna Institute for Psychedelic Plant Medicines that endeavors to advocate for the legality of sacred plant medicines among indigenous peoples and non-indigenous communities, encourage legal harm reduction practices that protect those who use them, educate about...

info_outline
Alicia Danforth PhD - ICPR 2020: Ethical Challenges in Psychedelic Medicine show art Alicia Danforth PhD - ICPR 2020: Ethical Challenges in Psychedelic Medicine

Psychedelics Today

In this episode, Joe interviews Clinical Psychologist, Alicia Danforth. In the show, they cover topics including how to get involved in the space, consent, research, MDMA, Autism and more. 3 Key Points: Alicia Danforth is a Clinical Psychologist who will be having a talk on Ethical Challenges in Psychedelic Medicine at the ICPR Conference in the Netherlands, April 2020. There is a possibility for MDMA to have a non-responder effect. No one has done research dedicated to why some people don't react at all to MDMA. Psychedelic science is very hard to talk about. We have the language of science...

info_outline
Mike Margolies - Psychedelic Seminars: the Benefits, Risks, and Complexities of Psychedelics show art Mike Margolies - Psychedelic Seminars: the Benefits, Risks, and Complexities of Psychedelics

Psychedelics Today

In this episode, Kyle and Joe interview Mike Margolies of Psychedelic Seminars. In the show, they cover topics including guests and conversations from the Psychedelic Seminars, the decriminalization of all drugs, and the importance of allowing psychedelic use to be a part of training therapists for psychedelic therapy. 3 Key Points: Psychedelic Seminars is an educational conversation series deepening awareness of the benefits, risks, and complexities of psychedelics. There are large topics of decriminalizing psilocybin or the movements for ‘decriminalize nature’, but the conversation on...

info_outline
Elizabeth Nielson and Ingmar Gorman - The Importance of Psychedelic Integration Training for Therapists show art Elizabeth Nielson and Ingmar Gorman - The Importance of Psychedelic Integration Training for Therapists

Psychedelics Today

In this Episode, Kyle sits down with Elizabeth Nielson and Ingmar Gorman, Co-founders of Fluence, Training in Psychedelic Integration. They are both therapists on the MAPS clinical trial for MDMA Assisted Psychotherapy for PTSD. 3 Key Points: Elizabeth and Ingmar are co-founders of Fluence, an online Psychedelic Integration Training program. If psychedelic treatments become available more widely, the fear is that therapists won't be as educated on how to handle their patient interactions based on the behavior of each psychedelic. Psychedelic Integration Therapy Training is so important. There...

info_outline
Jon S. - NYU’s Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence show art Jon S. - NYU’s Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence

Psychedelics Today

In this episode, Joe interviews Jon S. on his experience in the psilocybin-assisted trials for alcohol dependency at NYU. In the show, they dive into Jon’s background and how psilocybin assisted therapy helped him out of his alcohol dependence and into a new life. 3 Key Points: Jon participated in the NYU Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence. The study was double-blind. In each session, he didn't know if he was going to receive psilocybin or Benadryl.  The sessions helped him so much with this dependence on alcohol, he believes he is a better...

info_outline
Joost Breeksema - The Interdisciplinary Conference on Psychedelic Research show art Joost Breeksema - The Interdisciplinary Conference on Psychedelic Research

Psychedelics Today

In this episode, Joe interviews Joost Breeksema from the Netherlands to talk about the Interdisciplinary Conference on Psychedelic Research. In the show they cover topics on ICPR 2020, and the importance of accessibility. 3 Key Points: The Interdisciplinary Conference on Psychedelic Research takes place April 24-26, 2020 in the Netherlands. It's important to acknowledge the indigenous, ethical, and political dimensions to psychedelic use at conferences. Although this conference will be catered toward mainstream science and research, personal experiences and stories are important too. ...

info_outline
Hallie Rose and Kyle Buller - Soltara Healing Center and Kyle’s Experience with the Plant Medicine show art Hallie Rose and Kyle Buller - Soltara Healing Center and Kyle’s Experience with the Plant Medicine

Psychedelics Today

In this episode, Kyle invites a guest interviewer, Hallie Rose of the Thought Room Podcast, to interview him on his recent experience at Soltara. In the show, they talk about Soltara, Kyle’s experience with the plant medicine, and important topics like privilege.  3 Key Points: Eastern attendees have a different integration need than Western attendees. In the West, attendees come back to more hustle and bustle, more time is needed for integration. Soltara does a really good job at providing that time for integration.   With Psilocybin and other psychedelics, there is this one...

info_outline
 
More Episodes

In this Episode, Kyle sits down with Elizabeth Nielson and Ingmar Gorman, Co-founders of Fluence, Training in Psychedelic Integration. They are both therapists on the MAPS clinical trial for MDMA Assisted Psychotherapy for PTSD.

3 Key Points:

  1. Elizabeth and Ingmar are co-founders of Fluence, an online Psychedelic Integration Training program.
  2. If psychedelic treatments become available more widely, the fear is that therapists won't be as educated on how to handle their patient interactions based on the behavior of each psychedelic. Psychedelic Integration Therapy Training is so important.
  3. There are 3 phases to the MDMA for PTSD clinical trial. Phase 1 would be pre-clinical data about the chemistry of a drug, Phase 2 is where you begin to test your treatment in a patient population, and Phase 3 is where you get the data to demonstrate that the treatment is superior to a placebo and other treatments in general.

Support the show

Navigating Psychedelics


Show Notes

About Ingmar

  • Ingmar is a previous guest of the show
  • He is a private Investigator for the MAPS MDMA trial
  • He is a therapist and the Co-founder of Fluence

About Elizabeth

  • Elizabeth is a Clinical Psychologist
  • She has a long history in working with clinical trials as a therapist
  • She is part of the psychedelic education and continuing care program
  • She does a lot of supervision and training for therapists

The Trial

  • The approval of expanded access by the FDA includes 50 people in total
  • They are near the end of MAP 1 (out of MAP 1 and MAP 2)
    • When they transition into MAP 2, it will be a little more refined
    • MAP 2 is different participants than MAP 1
  • There are 3 phases
    • Phase 1 would be pre-clinical data about chemistry of a drug and how it metabolises, if its poisonous, etc
    • Phase 2 is where you begin to test your treatment in a patient population
    • Phase 3 is where you get the data to demonstrate that the treatment is superior to a placebo and other treatments in general
    • They are done as a double-blind trial, both the therapist and patient don't know if the patient is receiving the treatment or now

Take-aways

  • There is a lot of information that has to be shared effectively
  • The therapists are very much in the lives of the participants on top of just the MDMA
  • Instead of learning from the trials of what to do on a practical level, its about inspiring them to bring this as an actual treatment for people
  • The multiple ways that PTSD can manifest and look like, and the may ways that MDMA can look like when administered, have some commonalities
    • The deepening, the broadening, the way they communicate, can all be the same
  • Ingmar holds the belief in the inner healing intelligence of all people
    • One of the first things he does when he begins with a new patient, he says that this is something he really believes in, and his role as a therapist to help them in their own healing process and mechanism
  • What Elizabeth wanted to learn, know and practice while she was going through school, isn't what she she thought it was until she found it
    • She says this work really requires them to trust people's minds and experiences
    • There is something that they tell their patients, “Don't get ahead of the medicine” - Elizabeth
  • There is an interesting paradox between not knowing and following intuition, to having an actual method and following that
    • There is a sweet spot between following a script to following your intuition as a therapist
    • You want to trust that inner healer process of the patient, but also need to know when to intervene (usually from a safety standpoint)

Fluence

  • 3 days after Horizons, Elizabeth was at home with a cold, and talked to Ingmar that morning curious for a name for the project
  • Fluence means, magical or mystical power or source of power
    • It can also refer to the density of particles of energy
  • They teach about harm reduction and integration with their patients in their practice
    • They aren't teaching protocols in the workshops, they just think the harm reduction is important
  • The last part of integration is mindfulness
  • Ingmar’s biggest influence are his clients and patients, he is so inspired by them
    • A large piece of the motivation for creating Fluence is from patients just looking for someone to talk about their experience with

The Why

  • A mother whose teenage daughter with depression, reached out to Ingmar with trouble trying to treat her depression
    • The family decided it would be a good idea to use Ketamine therapy, which was successful
    • She was doing so well, so well that she then went to a therapist to integrate it
    • The therapist that she went to then instead of responding positively, decided to fire the teen for further therapy, and report the parents to child care services for providing ketamine therapy
    • Ingmar says their position is not that everyone needs psychedelic integration therapy, its specifically for those that don't feel supported by family or community, and it gives them a professional service as an option
  • "Psychedelics are not 10 years of change in one night, they are 10 years of insight in one night. integration is so important." - Elizabeth
  • The goal is to support people in making a change that feels safe and right for them
  • If the treatments become available more widely, the fear is that therapists won't be as educated on how to handle their patient interactions based on the behavior of each psychedelic
    • Mental health practitioners can be a great source for working through those experiences

Menla Training

  • Menla Training
  • They could really take their time with the process and training
  • The trainings that they had gone to has made their own Fluence courses better
  • In 2019 they had 5 of the trainings for clinicians, and the trainings will be better and better as they go

Ketamine Infusion Therapy

  • The experience is not dose dependent
  • The purpose of the workshop is to educate both therapists and doctors about what can happen in psychotherapy

Links

Fluence

Psychedelics 101 and 102 Workshop at ICPR 2020


About Elizabeth

Dr. Elizabeth Nielson is a co-founder of Fluence and a psychologist with a focus on developing psychedelic medicines as empirically supported treatments for PTSD, substance use problems, and mood disorders. Dr. Nielson is a therapist on FDA approved clinical trials of psilocybin-assisted treatment of alcohol use disorder, MDMA-assisted treatment PTSD, and psilocybin-assisted treatment of treatment resistant depression. Through Fluence, she provides continuing education and training programs for therapists who wish to engage in integration of psychedelic experiences in clinical settings. Her program of research includes qualitative and mixed-methods projects designed to further understand the phenomenology and mechanisms of change in psychedelic-assisted therapy, including the experiences of trial participants and of the therapists themselves. Having completed an NIH postdoctoral fellowship at NYU, she has published and presented on topics of psychedelic therapist training, therapists’ personal experience with psychedelics, and including psychedelic integration in group and individual psychotherapy.

About Ingmar

Dr. Ingmar Gorman is a co-founder of Fluence and a psychologist who specializes in assisting populations who have a relationship with psychedelics. He is the site co-principal investigator and therapist on a Phase 3 clinical trial studying MDMA-assisted psychotherapy for post-traumatic stress disorder. Dr. Gorman is a board member of Horizons Media, Inc., a not for-profit educational charity and organizer of the Horizons Conference: Perspectives on Psychedelics. After completing his NIH postdoctoral fellowship at New York University, Dr. Gorman stepped down as director of the Psychedelic Education and Continuing Care Program to focus his efforts on Fluence and the training of future therapists.

Designed to help the body with cellular energy and cardiovascular endurance.

Get a 30 day free audible trial at audibletrial.com/psychedelicstoday